Squarepoint Ops LLC lowered its stake in shares of Arteris, Inc. (NASDAQ:AIP – Free Report) by 12.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,383 shares of the company’s stock after selling 4,734 shares during the period. Squarepoint Ops LLC’s holdings in Arteris were worth $251,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Arteris by 0.3% during the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock worth $8,390,000 after purchasing an additional 3,242 shares during the last quarter. Renaissance Technologies LLC increased its holdings in Arteris by 6.1% during the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock valued at $861,000 after acquiring an additional 6,600 shares in the last quarter. GSA Capital Partners LLP raised its position in Arteris by 26.9% during the first quarter. GSA Capital Partners LLP now owns 132,952 shares of the company’s stock worth $973,000 after acquiring an additional 28,165 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Arteris by 2,182.8% in the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock valued at $239,000 after purchasing an additional 30,428 shares in the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong purchased a new stake in shares of Arteris in the second quarter valued at about $554,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Arteris
In other Arteris news, VP Paul L. Alpern sold 3,615 shares of the business’s stock in a transaction on Friday, October 4th. The shares were sold at an average price of $7.13, for a total transaction of $25,774.95. Following the completion of the sale, the vice president now owns 68,084 shares in the company, valued at $485,438.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, VP Paul L. Alpern sold 3,615 shares of Arteris stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $7.13, for a total transaction of $25,774.95. Following the sale, the vice president now owns 68,084 shares of the company’s stock, valued at approximately $485,438.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO K Charles Janac sold 5,520 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $7.18, for a total value of $39,633.60. Following the completion of the transaction, the chief executive officer now directly owns 287,247 shares of the company’s stock, valued at $2,062,433.46. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 135,360 shares of company stock valued at $988,781 over the last three months. 33.70% of the stock is owned by insiders.
Arteris Stock Performance
Arteris (NASDAQ:AIP – Get Free Report) last released its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The business had revenue of $14.58 million during the quarter, compared to analyst estimates of $13.68 million. During the same quarter last year, the firm posted ($0.25) EPS. As a group, equities research analysts expect that Arteris, Inc. will post -0.9 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently weighed in on AIP shares. Westpark Capital reissued a “buy” rating and set a $11.00 price objective on shares of Arteris in a research note on Wednesday, July 31st. Rosenblatt Securities restated a “buy” rating and set a $15.00 price objective on shares of Arteris in a report on Monday, August 5th.
Check Out Our Latest Stock Analysis on AIP
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- How to Use the MarketBeat Excel Dividend Calculator
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Stock Sentiment Analysis: How it Works
- MarketBeat Week in Review – 10/7 – 10/11
Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP – Free Report).
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.